sábado, 5 de julio de 2014

Preventing Chronic Disease | Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010 - CDC

full-text ►

Preventing Chronic Disease | Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010 - CDC



PCD Logo

Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010

Carla L. DeSisto, MPH; Shin Y. Kim, MPH; Andrea J. Sharma, MPH, PhD

Suggested citation for this article: DeSisto CL, Kim SY, Sharma AJ. Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis 2014;11:130415. DOI:http://dx.doi.org/10.5888/pcd11.130415External Web Site Icon.
PEER REVIEWED

Abstract

Introduction
The true prevalence of gestational diabetes mellitus (GDM) is unknown. The objective of this study was 1) to provide the most current GDM prevalence reported on the birth certificate and the Pregnancy Risk Assessment Monitoring System (PRAMS) questionnaire and 2) to compare GDM prevalence from PRAMS across 2007–2008 and 2009–2010.
Methods
We examined 2010 GDM prevalence reported on birth certificate or PRAMS questionnaire and concordance between the sources. We included 16 states that adopted the 2003 revised birth certificate. We also examined trends from 2007 through 2010 and included 21 states that participated in PRAMS for all 4 years. We combined GDM prevalence across 2-year intervals and conducted t tests to examine differences. Data were weighted to represent all women delivering live births in each state.
Results
GDM prevalence in 2010 was 4.6% as reported on the birth certificate, 8.7% as reported on the PRAMS questionnaire, and 9.2% as reported on either the birth certificate or questionnaire. The agreement between sources was 94.1% (percent positive agreement = 3.7%, percent negative agreement = 90.4%). There was no significant difference in GDM prevalence between 2007–2008 (8.1%) and 2009–2010 (8.5%, P = .15).


Conclusion
Our results indicate that GDM prevalence is as high as 9.2% and is more likely to be reported on the PRAMS questionnaire than the birth certificate. We found no statistical difference in GDM prevalence between the 2 phases. Further studies are needed to understand discrepancies in reporting GDM by data source.

Acknowledgments

All data included in this study were collected at the state level by the following PRAMS working group and their staff: Alabama — Izza Afgan, MPH; Alaska — Kathy Perham-Hester, MS, MPH; Arkansas — Mary McGehee, PhD; Colorado — Alyson Shupe, PhD; Connecticut — Jennifer Morin, MPH; Delaware — George Yocher, MS; Florida — Avalon Adams-Thames, MPH, CHES; Georgia — Chinelo Ogbuanu, MD, MPH, PhD; Hawaii — Emily Roberson, MPH; Illinois — Theresa Sandidge, MA; Iowa — Sarah Mauch, MPH; Louisiana — Amy Zapata, MPH; Maine — Tom Patenaude, MPH; Maryland — Diana Cheng, MD; Massachusetts — Emily Lu, MPH; Michigan — Cristin Larder, MS; Minnesota — Judy Punyko, PhD, MPH; Mississippi — Brenda Hughes, MPPA; Missouri — Venkata Garikapaty, MSc, MS, PhD, MPH; Montana — JoAnn Dotson; Nebraska — Brenda Coufal; New Hampshire — David J. Laflamme, PhD, MPH; New Jersey — Lakota Kruse, MD; New Mexico — Eirian Coronado, MPH; New York State — Anne Radigan-Garcia; New York City — Candace Mulready-Ward, MPH; North Carolina — Kathleen Jones-Vessey, MS; North Dakota — Sandra Anseth; Ohio — Connie Geidenberger, PhD; Oklahoma — Alicia Lincoln, MSW, MSPH; Oregon — Kenneth Rosenberg, MD, MPH; Pennsylvania — Tony Norwood; Rhode Island — Sam Viner-Brown, PhD; South Carolina — Mike Smith, MSPH; Texas — Rochelle Kingsley, MPH; Tennessee — David Law, PhD; Utah — Lynsey Gammon, MPH; Vermont — Peggy Brozicevic; Virginia — Marilyn Wenner; Washington — Linda Lohdefinck; West Virginia — Melissa Baker, MA; Wisconsin — Katherine Kvale, PhD; Wyoming — Amy Spieker, MPH; CDC PRAMS Team, Applied Sciences Branch, Division of Reproductive Health. The Centers for Disease Control and Prevention reviewed and approved this report before submission for publication. This research received no specific grant from any funding agency in the public, commercial, or nonprofit sectors.

Author Information

Corresponding Author: Carla L. DeSisto, Centers for Disease Control and Prevention, 601 Sunland Park Dr, Suite 200, El Paso, TX 79912. Telephone: 915-834-5958. E-mail: cdesisto@cdc.gov.
Author Affiliations: Shin Y. Kim, Andrea J. Sharma, Centers for Disease Control and Prevention, Atlanta, Georgia.

References

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36(Suppl 1):S67–74. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  2. Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes–a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 2012;12:23. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  3. Wong T, Ross GP, Jalaludin BB, Flack JR. The clinical significance of overt diabetes in pregnancy. Diabet Med 2013;30(4):468–74. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  4. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373(9677):1773–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  5. Dabelea D, Mayer-Davis EJ, Lamichhane AP, D’Agostino RB Jr, Liese AD, Vehik KS, et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care 2008;31(7):1422–6. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  6. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998;21(Suppl 2):B9–13.PubMedExternal Web Site Icon
  7. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278(13):1078–83. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  8. Hunsberger M, Rosenberg KD, Donatelle RJ. Racial/ethnic disparities in gestational diabetes mellitus: findings from a population-based survey. Womens Health Issues 2010;20(5):323–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  9. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34(2):173–99 [vii.]. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  10. Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, et al. Cost of gestational diabetes mellitus in the United States in 2007. Popul Health Manag 2009;12(3):165–74. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  11. Coustan DR. Gestational diabetes. In: National Institutes of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd edition. Bethesda (MD): NIDDK, 1995; NIH Publication No. 95-1468. p.703-17.
  12. Albrecht SS, Kuklina EV, Bansil P, Jamieson DJ, Whiteman MK, Kourtis AP, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care 2010;33(4):768–73. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  13. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Wilson EC, Mathews TJ. Births: final data for 2010. Natl Vital Stat Rep 2012;61(1):1–72.
  14. Devlin HM, Desai J, Walaszek A. Reviewing performance of birth certificate and hospital discharge data to identify births complicated by maternal diabetes. Matern Child Health J 2009;13(5):660–6. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  15. Owens-Gary MD, Ware J. Interventions to increase access to care and quality of care for women with gestational diabetes. Diabetes Spectr 2012;25(1):26-8.
  16. Osterman MJ, Martin JA, Menacker F. Expanded health data from the new birth certificate, 2006. Natl Vital Stat Rep 2009;58(5):1–24. PubMedExternal Web Site Icon
  17. Coustan DR, Lowe LP, Metzger BE, Dyer AR, International Association of Diabetes and Pregnancy Study Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 2010;202(6):654 e1-6. PubMedExternal Web Site Icon
  18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28(12):1039–57. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  19. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144(7):768–73. PubMedExternal Web Site Icon
  20. International Association of Diabetes Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676–82. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  21. National Institutes of Health Consensus Development Panel. NIH Consensus Development Conference Draft Statement. NIH Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus Conference 2013. http://prevention.nih.gov/cdp/conferences/2013/gdm/files/DraftStatement.pdf. Accessed May 1, 2013.
  22. Hay WW Jr. Care of the infant of the diabetic mother. Curr Diab Rep 2012;12(1):4–15. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  23. Bardenheier BH, Elixhauser A, Imperatore G, Devlin HM, Kuklina EV, Geiss LS, et al. Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care 2013;36(5):1209–14. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  24. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10(2):194–203. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  25. Kim SY, England L, Sappenfield W, Wilson HG, Bish CL, Salihu HM, et al. Racial/ethnic differences in the percentage of gestational diabetes mellitus cases attributable to overweight and obesity, Florida, 2004-2007. Prev Chronic Dis 2012;9:E88. PubMedExternal Web Site Icon
  26. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011;84(5):478–85. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  27. American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 313, September 2005. The importance of preconception care in the continuum of women’s health care. Obstet Gynecol 2005;106(3):665–6. PubMedExternal Web Site Icon
  28. Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS, et al. Recommendations to improve preconception health and health care–United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep 2006;55(RR-6):1–23. PubMedExternal Web Site Icon
  29. Cogswell ME, Power ML, Sharma AJ, Schulkin J. Prevention and management of obesity in nonpregnant women and adolescents: beliefs and practices of U.S. obstetricians and gynecologists. J Womens Health (Larchmt) 2010;19(9):1625–34. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  30. Racusin D, Stevens B, Campbell G, Aagaard KM. Obesity and the risk and detection of fetal malformations. Semin Perinatol 2012;36(3):213–21.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon

No hay comentarios: